Literature DB >> 15583950

Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy--a pilot study.

Judith D Bauer1, Sandra Capra.   

Abstract

GOALS OF THE WORK: The aim of this study was to examine the effect of nutrition intervention on outcomes of dietary intake, body composition, nutritional status, functional capacity and quality of life in patients with cancer cachexia receiving chemotherapy. PATIENTS AND METHODS: Patients received weekly counselling by a dietitian and were advised to consume a protein- and energy-dense oral nutritional supplement with eicosapentaenoic acid for 8 weeks. The medical oncologist determined the chemotherapy protocol. Eight patients enrolled and seven completed the study. MAIN
RESULTS: There were significant improvements in total protein intake (median change 0.3 g/kg per day, range -0.1 to 0.8 g/kg per day), total energy intake (median change 36 kJ/kg per day, range -2 to 82 kJ/kg per day), total fibre intake (median change 6.3 g/day, range -3.4 to 20.1 g/day), nutritional status (patient-generated subjective global assessment score, median change 9, range -5 to 17), Karnofsky performance status (median change 10, range 0-30) and quality of life (median change 16.7, range 0-33.3). There were clinically significant improvements in weight (median change 2.3 kg; range -2.7 to 4.5 kg) and lean body mass (median change 4.4 kg, range -4.4 to 4.7 kg), although these were not statistically significant. Change in nutritional status was significantly associated with change in quality of life, change in Karnofsky performance status and change in lean body mass.
CONCLUSIONS: Nutrition intervention together with chemotherapy improved outcomes in patients with pancreatic and non-small-cell lung cancer over 8 weeks. Supplement intake does not inhibit meal intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583950     DOI: 10.1007/s00520-004-0746-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  17 in total

Review 1.  Nutritional support of the cancer patient: issues and dilemmas.

Authors:  G Nitenberg; B Raynard
Journal:  Crit Rev Oncol Hematol       Date:  2000-06       Impact factor: 6.312

2.  What is subjective global assessment of nutritional status?

Authors:  A S Detsky; J R McLaughlin; J P Baker; N Johnston; S Whittaker; R A Mendelson; K N Jeejeebhoy
Journal:  JPEN J Parenter Enteral Nutr       Date:  1987 Jan-Feb       Impact factor: 4.016

3.  Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.

Authors:  J F Vansteenkiste; J E Vandebroek; K L Nackaerts; P Weynants; Y J Valcke; D A Verresen; R C Devogelaere; S A Marien; Y P Humblet; N L Dams
Journal:  Ann Oncol       Date:  2001-09       Impact factor: 32.976

Review 4.  The role of gemcitabine alone and in combination in the treatment of pancreatic cancer.

Authors:  H Oettle; D Arnold; C Hempel; H Riess
Journal:  Anticancer Drugs       Date:  2000-11       Impact factor: 2.248

5.  An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

Authors:  Aminah Jatoi; Kendrith Rowland; Charles L Loprinzi; Jeff A Sloan; Shaker R Dakhil; Neil MacDonald; Bruno Gagnon; Paul J Novotny; James A Mailliard; Teresita I L Bushey; Suresh Nair; Brad Christensen
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

6.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

7.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

8.  Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study.

Authors:  Eduardo Bruera; Florian Strasser; J Lynn Palmer; Jie Willey; Kathryn Calder; Gail Amyotte; Vickie Baracos
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

9.  The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.

Authors:  M D Barber; J A Ross; A C Voss; M J Tisdale; K C Fearon
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

10.  Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.

Authors:  A W G Moses; C Slater; T Preston; M D Barber; K C H Fearon
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

View more
  39 in total

1.  Teaching nutrition integration: MUST screening in cancer.

Authors:  Carolina Boléo-Tomé; Mariana Chaves; Isabel Monteiro-Grillo; Maria Camilo; Paula Ravasco
Journal:  Oncologist       Date:  2011-01-27

2.  Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis.

Authors:  Zoe Giannousi; Ioannis Gioulbasanis; Athanasios G Pallis; Alexandros Xyrafas; Danai Dalliani; Kostas Kalbakis; Vassilis Papadopoulos; Dimitris Mavroudis; Vassilis Georgoulias; Christos N Papandreou
Journal:  Support Care Cancer       Date:  2011-10-01       Impact factor: 3.603

3.  Early Oral Feeding After Surgery for Upper Gastrointestinal Malignancies: A Prospective Cohort Study.

Authors:  Saeed Shoar; Mohammad Naderan; Habibollah Mahmoodzadeh; Negin Hosseini-Araghi; Nastaran Mahboobi; Freydoon Sirati; Zhamak Khorgami
Journal:  Oman Med J       Date:  2016-05

Review 4.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

5.  A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy.

Authors:  Kazuhiro Migita; Sohei Matsumoto; Kohei Wakatsuki; Masahiro Ito; Tomohiro Kunishige; Hiroshi Nakade; Mutsuko Kitano; Mitsuhiro Nakatani; Hiromichi Kanehiro
Journal:  Surg Today       Date:  2017-03-01       Impact factor: 2.549

6.  Early initiation of oral feeding following upper gastrointestinal tumor surgery: a randomized controlled trial.

Authors:  Habibollah Mahmoodzadeh; Saeed Shoar; Freydoon Sirati; Zhamak Khorgami
Journal:  Surg Today       Date:  2014-05-30       Impact factor: 2.549

7.  Impact of weight loss on cancer patients' quality of life at the beginning of the chemotherapy.

Authors:  Elena Álvaro Sanz; Jimena Abilés; Margarita Garrido Siles; Elísabeth Pérez Ruíz; Julia Alcaide García; Antonio Rueda Domínguez
Journal:  Support Care Cancer       Date:  2020-05-18       Impact factor: 3.603

8.  Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.

Authors:  Jane A Read; Philip J Beale; Dianne H Volker; Narelle Smith; Annabel Childs; Stephen J Clarke
Journal:  Support Care Cancer       Date:  2006-10-05       Impact factor: 3.603

9.  Effects of nutritional and psychological status of the patients with advanced stomach cancer on physical performance status.

Authors:  Jun Tian; Zhen-chun Chen; Li-Fang Hang
Journal:  Support Care Cancer       Date:  2009-01-27       Impact factor: 3.603

10.  Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma.

Authors:  Motokazu Sugimoto; Michael B Farnell; David M Nagorney; Michael L Kendrick; Mark J Truty; Rory L Smoot; Suresh T Chari; Michael R Moynagh; Gloria M Petersen; Rickey E Carter; Naoki Takahashi
Journal:  J Gastrointest Surg       Date:  2018-02-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.